ID   HDAC7_MOUSE             Reviewed;         938 AA.
AC   Q8C2B3; Q8C2C9; Q8C8X4; Q8CB80; Q8CDA3; Q9JL72;
DT   16-MAY-2003, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2003, sequence version 2.
DT   04-FEB-2015, entry version 129.
DE   RecName: Full=Histone deacetylase 7;
DE            Short=HD7;
DE            EC=3.5.1.98;
DE   AltName: Full=Histone deacetylase 7A;
DE            Short=HD7a;
GN   Name=Hdac7; Synonyms=Hdac7a;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND INTERACTION WITH NCOR2 AND SIN3A.
RC   STRAIN=C57BL/6; TISSUE=Brain;
RX   PubMed=10640276;
RA   Kao H.-Y., Downes M., Ordentlich P., Evans R.M.;
RT   "Isolation of a novel histone deacetylase reveals that class I and
RT   class II deacetylases promote SMRT-mediated repression.";
RL   Genes Dev. 14:55-66(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3; 4; 5 AND 6).
RC   STRAIN=C57BL/6J, and NOD; TISSUE=Bone, Retina, and Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=C57BL/6; TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   INTERACTION WITH HDAC1; HDAC2; HDAC3; HDAC4; HDAC5; NCOR1; NCOR2;
RP   SIN3A; SIN3B; RBBP4; RBBP7; MTA1L1; SAP30 AND MBD3, AND MUTAGENESIS OF
RP   HIS-657; ASP-692; ASP-694 AND HIS-717.
RX   PubMed=10984530; DOI=10.1073/pnas.97.19.10330;
RA   Downes M., Ordentlich P., Kao H.-Y., Alvarez J.G.A., Evans R.M.;
RT   "Identification of a nuclear domain with deacetylase activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:10330-10335(2000).
RN   [5]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, INTERACTION WITH MEF2C, AND
RP   MUTAGENESIS OF HIS-657.
RX   PubMed=11279209; DOI=10.1074/jbc.M101508200;
RA   Dressel U., Bailey P.J., Wang S.-C.M., Downes M., Evans R.M.,
RA   Muscat G.E.O.;
RT   "A dynamic role for HDAC7 in MEF2-mediated muscle differentiation.";
RL   J. Biol. Chem. 276:17007-17013(2001).
RN   [6]
RP   SUBCELLULAR LOCATION, PHOSPHORYLATION, INTERACTION WITH YWHAE; MEF2A;
RP   MEF2B AND MEF2C, AND MUTAGENESIS OF SER-178; SER-344 AND SER-479.
RX   PubMed=11585834; DOI=10.1074/jbc.M107631200;
RA   Kao H.-Y., Verdel A., Tsai C.-C., Simon C., Juguilon H., Khochbin S.;
RT   "Mechanism for nucleocytoplasmic shuttling of histone deacetylase 7.";
RL   J. Biol. Chem. 276:47496-47507(2001).
RN   [7]
RP   NUCLEAR EXPORT SIGNAL.
RX   PubMed=11509672; DOI=10.1128/MCB.21.18.6312-6321.2001;
RA   McKinsey T.A., Zhang C.-L., Olson E.N.;
RT   "Identification of a signal-responsive nuclear export sequence in
RT   class II histone deacetylases.";
RL   Mol. Cell. Biol. 21:6312-6321(2001).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [9]
RP   PHOSPHORYLATION AT SER-178; SER-344 AND SER-479.
RX   PubMed=18509061; DOI=10.1073/pnas.0802857105;
RA   Wang S., Li X., Parra M., Verdin E., Bassel-Duby R., Olson E.N.;
RT   "Control of endothelial cell proliferation and migration by VEGF
RT   signaling to histone deacetylase 7.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:7738-7743(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=19131326; DOI=10.1074/mcp.M800451-MCP200;
RA   Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.;
RT   "Large scale localization of protein phosphorylation by use of
RT   electron capture dissociation mass spectrometry.";
RL   Mol. Cell. Proteomics 8:904-912(2009).
RN   [11]
RP   INTERACTION WITH ZMYND15.
RX   PubMed=20675388; DOI=10.1074/jbc.M110.116418;
RA   Yan W., Si Y., Slaymaker S., Li J., Zheng H., Young D.L., Aslanian A.,
RA   Saunders L., Verdin E., Charo I.F.;
RT   "Zmynd15 encodes a histone deacetylase-dependent transcriptional
RT   repressor essential for spermiogenesis and male fertility.";
RL   J. Biol. Chem. 285:31418-31426(2010).
CC   -!- FUNCTION: Responsible for the deacetylation of lysine residues on
CC       the N-terminal part of the core histones (H2A, H2B, H3 and H4).
CC       Histone deacetylation gives a tag for epigenetic repression and
CC       plays an important role in transcriptional regulation, cell cycle
CC       progression and developmental events. Histone deacetylases act via
CC       the formation of large multiprotein complexes. Involved in muscle
CC       maturation by repressing transcription of myocyte enhancer factors
CC       such as MEF2A, MEF2B and MEF2C. During muscle differentiation, it
CC       shuttles into the cytoplasm, allowing the expression of myocyte
CC       enhancer factors. {ECO:0000269|PubMed:10640276}.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of an N(6)-acetyl-lysine residue of
CC       a histone to yield a deacetylated histone.
CC   -!- SUBUNIT: Interacts with KDM5B (By similarity). Interacts with KAT5
CC       and EDNRA. Interacts with HDAC1, HDAC2, HDAC3, HDAC4, HDAC5,
CC       NCOR1, NCOR2, SIN3A, SIN3B, RBBP4, RBBP7, MTA1L1, SAP30 and MBD3.
CC       Interacts with the 14-3-3 protein YWHAE, MEF2A, MEF2B and MEF2C.
CC       Interacts with ZMYND15. Interacts with PML (By similarity).
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       P62259:Ywhae; NbExp=6; IntAct=EBI-643830, EBI-356480;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=In the nucleus, it
CC       associates with distinct subnuclear dot-like structures. Shuttles
CC       between the nucleus and the cytoplasm. In muscle cells, it
CC       shuttles into the cytoplasm during myocyte differentiation. The
CC       export to cytoplasm depends on the interaction with the 14-3-3
CC       protein YWHAE and is due to its phosphorylation.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q8C2B3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8C2B3-2; Sequence=VSP_007432, VSP_007434, VSP_007435;
CC       Name=3;
CC         IsoId=Q8C2B3-3; Sequence=VSP_007432, VSP_007434;
CC       Name=4;
CC         IsoId=Q8C2B3-4; Sequence=VSP_007433, VSP_007434, VSP_007435;
CC       Name=5;
CC         IsoId=Q8C2B3-5; Sequence=VSP_007432;
CC       Name=6;
CC         IsoId=Q8C2B3-6; Sequence=VSP_007433;
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart and lung. Expressed
CC       at intermediate level in muscle. {ECO:0000269|PubMed:10640276,
CC       ECO:0000269|PubMed:11279209}.
CC   -!- DOMAIN: The nuclear export sequence mediates the shuttling between
CC       the nucleus and the cytoplasm. {ECO:0000250}.
CC   -!- PTM: May be phosphorylated by CaMK1. Phosphorylated by the PKC
CC       kinases PKN1 and PKN2, impairing nuclear import. Phosphorylation
CC       at Ser-178 by MARK2, MARK3 and PRKD1 promotes interaction with 14-
CC       3-3 proteins and export from the nucleus. Phosphorylation at Ser-
CC       178 is a prerequisite for phosphorylation at Ser-204 (By
CC       similarity). {ECO:0000250}.
CC   -!- MISCELLANEOUS: Its activity is inhibited by Trichostatin A (TSA),
CC       a known histone deacetylase inhibitor.
CC   -!- SIMILARITY: Belongs to the histone deacetylase family. HD type 2
CC       subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF207749; AAF31419.1; -; mRNA.
DR   EMBL; AK030863; BAC27161.1; -; mRNA.
DR   EMBL; AK036586; BAC29493.1; -; mRNA.
DR   EMBL; AK044287; BAC31856.1; -; mRNA.
DR   EMBL; AK088828; BAC40598.1; -; mRNA.
DR   EMBL; AK088945; BAC40666.1; -; mRNA.
DR   EMBL; BC057332; AAH57332.1; -; mRNA.
DR   CCDS; CCDS37188.1; -. [Q8C2B3-1]
DR   CCDS; CCDS57004.1; -. [Q8C2B3-5]
DR   CCDS; CCDS57005.1; -. [Q8C2B3-2]
DR   CCDS; CCDS57006.1; -. [Q8C2B3-3]
DR   CCDS; CCDS57007.1; -. [Q8C2B3-4]
DR   RefSeq; NP_001191204.1; NM_001204275.1. [Q8C2B3-3]
DR   RefSeq; NP_001191205.1; NM_001204276.1. [Q8C2B3-2]
DR   RefSeq; NP_001191206.1; NM_001204277.1. [Q8C2B3-4]
DR   RefSeq; NP_001191207.1; NM_001204278.1. [Q8C2B3-5]
DR   RefSeq; NP_062518.2; NM_019572.3. [Q8C2B3-1]
DR   RefSeq; XP_006521268.1; XM_006521205.1.
DR   RefSeq; XP_006521269.1; XM_006521206.1. [Q8C2B3-3]
DR   RefSeq; XP_006521270.1; XM_006521207.1. [Q8C2B3-3]
DR   RefSeq; XP_006521271.1; XM_006521208.1. [Q8C2B3-3]
DR   RefSeq; XP_006521272.1; XM_006521209.1. [Q8C2B3-3]
DR   RefSeq; XP_006521273.1; XM_006521210.1. [Q8C2B3-3]
DR   UniGene; Mm.384027; -.
DR   ProteinModelPortal; Q8C2B3; -.
DR   SMR; Q8C2B3; 507-887.
DR   BioGrid; 207862; 5.
DR   DIP; DIP-42594N; -.
DR   IntAct; Q8C2B3; 4.
DR   MINT; MINT-1551781; -.
DR   PhosphoSite; Q8C2B3; -.
DR   MaxQB; Q8C2B3; -.
DR   PaxDb; Q8C2B3; -.
DR   PRIDE; Q8C2B3; -.
DR   Ensembl; ENSMUST00000079838; ENSMUSP00000078766; ENSMUSG00000022475. [Q8C2B3-4]
DR   Ensembl; ENSMUST00000088402; ENSMUSP00000085744; ENSMUSG00000022475. [Q8C2B3-1]
DR   Ensembl; ENSMUST00000116408; ENSMUSP00000112109; ENSMUSG00000022475. [Q8C2B3-5]
DR   Ensembl; ENSMUST00000116409; ENSMUSP00000112110; ENSMUSG00000022475. [Q8C2B3-3]
DR   Ensembl; ENSMUST00000118294; ENSMUSP00000113380; ENSMUSG00000022475. [Q8C2B3-2]
DR   GeneID; 56233; -.
DR   KEGG; mmu:56233; -.
DR   UCSC; uc007xle.2; mouse. [Q8C2B3-1]
DR   UCSC; uc007xlf.2; mouse. [Q8C2B3-2]
DR   UCSC; uc007xlg.2; mouse. [Q8C2B3-4]
DR   UCSC; uc007xlh.2; mouse. [Q8C2B3-3]
DR   CTD; 51564; -.
DR   MGI; MGI:1891835; Hdac7.
DR   eggNOG; COG0123; -.
DR   GeneTree; ENSGT00530000062809; -.
DR   HOGENOM; HOG000232065; -.
DR   HOVERGEN; HBG057100; -.
DR   InParanoid; Q8C2B3; -.
DR   KO; K11408; -.
DR   OMA; AFRIVVM; -.
DR   OrthoDB; EOG7RFTH5; -.
DR   PhylomeDB; Q8C2B3; -.
DR   TreeFam; TF106173; -.
DR   Reactome; REACT_196464; NOTCH1 Intracellular Domain Regulates Transcription.
DR   Reactome; REACT_196589; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; REACT_196591; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   ChiTaRS; Hdac7; mouse.
DR   NextBio; 312136; -.
DR   PMAP-CutDB; Q8C2B3; -.
DR   PRO; PR:Q8C2B3; -.
DR   Proteomes; UP000000589; Chromosome 15.
DR   Bgee; Q8C2B3; -.
DR   CleanEx; MM_HDAC7; -.
DR   ExpressionAtlas; Q8C2B3; baseline and differential.
DR   Genevestigator; Q8C2B3; -.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0000118; C:histone deacetylase complex; TAS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0071889; F:14-3-3 protein binding; ISS:UniProtKB.
DR   GO; GO:0033613; F:activating transcription factor binding; ISO:MGI.
DR   GO; GO:0003682; F:chromatin binding; IDA:MGI.
DR   GO; GO:0004407; F:histone deacetylase activity; TAS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0032041; F:NAD-dependent histone deacetylase activity (H3-K14 specific); IEA:UniProtKB-EC.
DR   GO; GO:0097372; F:NAD-dependent histone deacetylase activity (H3-K18 specific); IEA:UniProtKB-EC.
DR   GO; GO:0046969; F:NAD-dependent histone deacetylase activity (H3-K9 specific); IEA:UniProtKB-EC.
DR   GO; GO:0046970; F:NAD-dependent histone deacetylase activity (H4-K16 specific); IEA:UniProtKB-EC.
DR   GO; GO:0019901; F:protein kinase binding; ISO:MGI.
DR   GO; GO:0005080; F:protein kinase C binding; ISO:MGI.
DR   GO; GO:0070491; F:repressing transcription factor binding; ISO:MGI.
DR   GO; GO:0003714; F:transcription corepressor activity; IDA:MGI.
DR   GO; GO:0008134; F:transcription factor binding; TAS:UniProtKB.
DR   GO; GO:0042113; P:B cell activation; TAS:UniProtKB.
DR   GO; GO:0030183; P:B cell differentiation; TAS:UniProtKB.
DR   GO; GO:0007043; P:cell-cell junction assembly; IMP:MGI.
DR   GO; GO:0016568; P:chromatin modification; TAS:UniProtKB.
DR   GO; GO:0016575; P:histone deacetylation; TAS:GOC.
DR   GO; GO:0006954; P:inflammatory response; TAS:UniProtKB.
DR   GO; GO:0032703; P:negative regulation of interleukin-2 production; ISO:MGI.
DR   GO; GO:0045668; P:negative regulation of osteoblast differentiation; ISO:MGI.
DR   GO; GO:0045843; P:negative regulation of striated muscle tissue development; TAS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:MGI.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; TAS:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; TAS:UniProtKB.
DR   GO; GO:0090050; P:positive regulation of cell migration involved in sprouting angiogenesis; ISO:MGI.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0001570; P:vasculogenesis; IMP:MGI.
DR   Gene3D; 3.40.800.20; -; 1.
DR   InterPro; IPR000286; His_deacetylse.
DR   InterPro; IPR023801; His_deacetylse_dom.
DR   InterPro; IPR017320; Histone_deAcase_II_euk.
DR   PANTHER; PTHR10625; PTHR10625; 1.
DR   Pfam; PF00850; Hist_deacetyl; 1.
DR   PIRSF; PIRSF037911; HDAC_II_euk; 1.
DR   PRINTS; PR01270; HDASUPER.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromatin regulator; Complete proteome;
KW   Cytoplasm; Hydrolase; Metal-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Zinc.
FT   CHAIN         1    938       Histone deacetylase 7.
FT                                /FTId=PRO_0000114706.
FT   REGION        1    121       Interaction with MEF2C.
FT   REGION        2    254       Transcription repression 1.
FT   REGION       72    172       Interaction with MEF2A.
FT   REGION      241    533       Transcription repression 2.
FT   REGION      505    852       Histone deacetylase.
FT   REGION      864    938       Interaction with SIN3A.
FT   MOTIF       904    938       Nuclear export signal. {ECO:0000250}.
FT   COMPBIAS    220    226       Poly-Ser.
FT   ACT_SITE    657    657       {ECO:0000250}.
FT   METAL       520    520       Zinc. {ECO:0000250}.
FT   METAL       522    522       Zinc. {ECO:0000250}.
FT   METAL       528    528       Zinc. {ECO:0000250}.
FT   METAL       605    605       Zinc. {ECO:0000250}.
FT   SITE        830    830       Contributes to catalysis. {ECO:0000250}.
FT   MOD_RES     132    132       Phosphoserine. {ECO:0000250}.
FT   MOD_RES     178    178       Phosphoserine; by MARK2, MARK3 and
FT                                PKD/PRKD1. {ECO:0000305|PubMed:18509061}.
FT   MOD_RES     204    204       Phosphoserine; by PKD/PRKD2.
FT                                {ECO:0000250}.
FT   MOD_RES     344    344       Phosphoserine; by PKD/PRKD1.
FT                                {ECO:0000269|PubMed:18509061}.
FT   MOD_RES     479    479       Phosphoserine; by PKD/PRKD1.
FT                                {ECO:0000269|PubMed:18509061}.
FT   VAR_SEQ       1     22       Missing (in isoform 2, isoform 3 and
FT                                isoform 5).
FT                                {ECO:0000303|PubMed:16141072}.
FT                                /FTId=VSP_007432.
FT   VAR_SEQ     138    161       Missing (in isoform 4 and isoform 6).
FT                                {ECO:0000303|PubMed:16141072}.
FT                                /FTId=VSP_007433.
FT   VAR_SEQ     249    249       E -> EALLGQRLRLQETSLAPFALPTVSLLPAITLGLPAP
FT                                AR (in isoform 2, isoform 3 and isoform
FT                                4). {ECO:0000303|PubMed:16141072}.
FT                                /FTId=VSP_007434.
FT   VAR_SEQ     376    382       Missing (in isoform 2 and isoform 4).
FT                                {ECO:0000303|PubMed:16141072}.
FT                                /FTId=VSP_007435.
FT   MUTAGEN     178    178       S->A: Strong reduction of CaMK1-dependent
FT                                nuclear export. Reduces interaction with
FT                                YWHAE. {ECO:0000269|PubMed:11585834}.
FT   MUTAGEN     344    344       S->A: Strong reduction of CaMK1-dependent
FT                                nuclear export. Reduces interaction with
FT                                YWHAE. {ECO:0000269|PubMed:11585834}.
FT   MUTAGEN     479    479       S->A: Strong reduction of CaMK1-dependent
FT                                nuclear export. Reduces interaction with
FT                                YWHAE. {ECO:0000269|PubMed:11585834}.
FT   MUTAGEN     657    657       H->A: Abolishes deacetylase activity, but
FT                                not the interaction with HDAC2 and HDAC3.
FT                                {ECO:0000269|PubMed:10984530,
FT                                ECO:0000269|PubMed:11279209}.
FT   MUTAGEN     692    692       D->A: Disrupts the dot-like nuclear
FT                                pattern. {ECO:0000269|PubMed:10984530}.
FT   MUTAGEN     694    694       D->A: Disrupts the dot-like nuclear
FT                                pattern. Abolishes deacetylase activity,
FT                                but not the interaction with HDAC2 and
FT                                HDAC3. {ECO:0000269|PubMed:10984530}.
FT   MUTAGEN     717    717       H->A: Abolishes deacetylase activity, but
FT                                not the interaction with HDAC2 and HDAC3.
FT                                {ECO:0000269|PubMed:10984530}.
FT   CONFLICT    169    169       E -> G (in Ref. 2; BAC27161).
FT                                {ECO:0000305}.
FT   CONFLICT    183    183       K -> M (in Ref. 2; BAC29493).
FT                                {ECO:0000305}.
FT   CONFLICT    228    228       P -> T (in Ref. 2; BAC27161).
FT                                {ECO:0000305}.
FT   CONFLICT    487    487       L -> M (in Ref. 1; AAF31419 and 2;
FT                                BAC40598/BAC40666). {ECO:0000305}.
FT   CONFLICT    645    645       K -> R (in Ref. 2; BAC29493).
FT                                {ECO:0000305}.
FT   CONFLICT    661    661       S -> P (in Ref. 2; BAC40598).
FT                                {ECO:0000305}.
FT   CONFLICT    737    737       G -> A (in Ref. 1; AAF31419).
FT                                {ECO:0000305}.
SQ   SEQUENCE   938 AA;  101287 MW;  8D4B455CE6F95483 CRC64;
     MHSPGAGCPA LQPDTPGSQP QPMDLRVGQR PTVEPPPEPA LLTLQHPQRL HRHLFLAGLH
     QQQRSAEPMR LSMDPPMPEL QGGQQEQELR QLLNKDKSKR SAVASSVVKQ KLAEVILKKQ
     QAALERTVHP SSPSIPYRTL EPLDTEGAAR SVLSSFLPPV PSLPTEPPEH FPLRKTVSEP
     NLKLRYKPKK SLERRKNPLL RKESAPPSLR RRPAETLGDS SPSSSSTPAS GCSSPNDSEH
     GPNPALGSEA DGDRRTHSTL GPRGPVLGNP HAPLFLHHGL EPEAGGTLPS RLQPILLLDP
     SVSHAPLWTV PGLGPLPFHF AQPLLTTERL SGSGLHRPLN RTRSEPLPPS ATASPLLAPL
     QPRQDRLKPH VQLIKPAISP PQRPAKPSEK PRLRQIPSAE DLETDGGGVG PMANDGLEHR
     ESGRGPPEGR GSISLQQHQQ VPPWEQQHLA GRLSQGSPGD SVLIPLAQVG HRPLSRTQSS
     PAAPVSLLSP EPTCQTQVLN SSETPATGLV YDSVMLKHQC SCGDNSKHPE HAGRIQSIWS
     RLQERGLRSQ CECLRGRKAS LEELQSVHSE RHVLLYGTNP LSRLKLDNGK LTGLLAQRTF
     VMLPCGGVGV DTDTIWNELH SSNAARWAAG SVTDLAFKVA SRELKNGFAV VRPPGHHADH
     STAMGFCFFN SVAIACRQLQ QHGKASKILI VDWDVHHGNG TQQTFYQDPS VLYISLHRHD
     DGNFFPGSGA VDEVGTGSGE GFNVNVAWAG GLDPPMGDPE YLAAFRIVVM PIAREFAPDL
     VLVSAGFDAA EGHPAPLGGY HVSAKCFGYM TQQLMNLAGG AVVLALEGGH DLTAICDASE
     ACVAALLGNK VDPLSEESWK QKPNLSAIRS LEAVVRVHRK YWGCMQRLAS CPDSWLPRVP
     GADAEVEAVT ALASLSVGIL AEDRPSERLV EEEEPMNL
//
